Catalyst OrthoScience Inc.
PrivateLast Round
Series G
Oct 22, 2025
Est. Valuation
$117.5M
Total Funding Raised
$72.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Catalyst OrthoScience Inc. is a medical device company that develops and markets shoulder replacement systems designed to make orthopedic surgery less invasive and more efficient.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Catalyst OrthoScience Inc. Comparables
Compare Catalyst OrthoScience Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shoulder Innovations | 89% | |
| Enovis Corp | 80% | |
| Exactech | 79% |
Catalyst OrthoScience Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series G | Oct 22, 2025 | ||||
| VC Round | Jul 31, 2025 | ||||
| Debt | Sep 10, 2024 | ||||
| Series D | Oct 6, 2021 | ||||
| Series C | May 14, 2019 | ||||
Series B | Nov 29, 2017 |
Key People
Founding team and executive leadership
Catalyst OrthoScience Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mutual Capital Partners | Debt, Series G, Series D |
| River Cities Capital | Debt |
| RC Capital | Debt, Series C, Series D, Series G |
| Bridge Bank | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 25, 2026
Received 510(k) clearance for Archer Patient-Specific Instrumentation.
- Oct 22, 2025
$15M raised in debt financing.
Recent news
Latest coverage and updates
- is_developingOct 13, 2026
As of Oct 13th '26, Catalyst OrthoScience Inc. is developing single-tray instrumentation for the Catalyst Fracture Shoulder System with input from surgeons, O.R. teams, and healthcare organizations to reduce financial, logistical, and cognitive burdens while maintaining clinical performance.
- partners_withSep 23, 2026
Catalyst OrthoScience Inc. joins Redefine Surgery as founding shoulder partner in Florida on Sep 23rd '26
Catalyst OrthoScience Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Catalyst OrthoScience Inc.'s valuation, stock price, and market status.
Is Catalyst OrthoScience Inc. a public or private company?
Catalyst OrthoScience Inc. is a private company.
What is the current stock price of Catalyst OrthoScience Inc.?
Catalyst OrthoScience Inc. is a private company, so its shares have no public market price. Caplight tracks Catalyst OrthoScience Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Catalyst OrthoScience Inc. worth (valuation)?
Catalyst OrthoScience Inc.'s valuation is estimated at $117.5M based on funding round data.
Can I buy Catalyst OrthoScience Inc. stock?
Catalyst OrthoScience Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Catalyst OrthoScience Inc.'s last funding round?
Catalyst OrthoScience Inc.'s most recent funding round was Series G on October 22, 2025.
Who are the main investors in Catalyst OrthoScience Inc.?
Key investors in Catalyst OrthoScience Inc. include Mutual Capital Partners, RC Capital.
Will Catalyst OrthoScience Inc. IPO soon?
No public IPO plans have been announced for Catalyst OrthoScience Inc..
How can I track Catalyst OrthoScience Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Catalyst OrthoScience Inc.'s shares on secondary markets.